02/22/2024 7:00 AM | Edgewise Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 7:07 AM | Edgewise Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 9:26 AM | Edgewise Therapeutics (Subject) VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G/A | |
02/14/2024 7:43 AM | Deep Track Capital, LP (Filed by) Edgewise Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024 4:42 PM | Derakhshan Behrad (Reporting) Edgewise Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 4:43 PM | Edgewise Therapeutics (Issuer) MOORE JOHN R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/07/2024 3:18 PM | Edgewise Therapeutics (Subject) MOORE JOHN R (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
02/01/2024 4:28 PM | Edgewise Therapeutics (Subject) Flynn James E (Filed by)
| Form SC 13G/A | |
01/29/2024 3:30 PM | Edgewise Therapeutics (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
01/23/2024 3:19 PM | Carruthers R Michael (Reporting) Edgewise Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/19/2024 3:54 PM | Edgewise Therapeutics (Filer)
| Form 424B5 | |
01/19/2024 7:44 AM | Edgewise Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/19/2024 5:02 AM | Edgewise Therapeutics (Filer)
| Form 424B3 | |
01/19/2024 5:04 AM | Edgewise Therapeutics (Filer)
| Form S-3MEF | |
01/19/2024 5:05 AM | Edgewise Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/28/2023 3:38 PM | Edgewise Therapeutics (Issuer) Russell Alan J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 3:39 PM | Edgewise Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 3:39 PM | Edgewise Therapeutics (Issuer) MOORE JOHN R (Reporting) MOORE JOHN R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 3:39 PM | Edgewise Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 3:39 PM | Edgewise Therapeutics (Issuer) Fox Jonathan C (Reporting) Fox Jonathan C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2023 3:22 PM | Edgewise Therapeutics (Subject) MOORE JOHN R (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2023 3:32 PM | Edgewise Therapeutics (Subject) Russell Alan J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/09/2023 7:00 AM | Edgewise Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 7:05 AM | Edgewise Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/18/2023 6:12 PM | Edgewise Therapeutics (Issuer) KOCH KEVIN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/18/2023 6:13 PM | Donovan Joanne M. (Reporting) Edgewise Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/18/2023 6:13 PM | Edgewise Therapeutics (Issuer) Semigran Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/18/2023 6:13 PM | Edgewise Therapeutics (Issuer) Russell Alan J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/18/2023 6:13 PM | Carruthers R Michael (Reporting) Edgewise Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/18/2023 6:13 PM | Edgewise Therapeutics (Issuer) MOORE JOHN R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/18/2023 6:13 PM | Derakhshan Behrad (Reporting) Edgewise Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/10/2023 7:00 AM | Edgewise Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/10/2023 7:01 AM | Edgewise Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/14/2023 3:05 PM | Edgewise Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/28/2023 3:17 PM | Edgewise Therapeutics (Subject) Novo Holdings A/S (Filed by)
| Form SC 13D/A | |
06/26/2023 3:28 PM | Carruthers R Michael (Reporting) Edgewise Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 8:57 PM | Edgewise Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/16/2023 3:08 PM | Edgewise Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/14/2023 6:29 PM | Brege Laura (Reporting) Edgewise Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2023 6:29 PM | Edgewise Therapeutics (Issuer) Edris Badreddin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2023 6:29 PM | Edgewise Therapeutics (Issuer) ROOT JONATHAN D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
A.I. Pioneer Issues Urgent Warning to Americans (Ad) With artificial intelligence creeping into every facet of our lives, what should you be doing to "A.I.-Proof" your future?
It's the question on many of our minds. Click here to see Louis' new video for yourself. |
06/14/2023 6:29 PM | Edgewise Therapeutics (Issuer) Thompson Peter A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2023 6:30 PM | Edgewise Therapeutics (Issuer) Fox Jonathan C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/11/2023 7:01 AM | Edgewise Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/11/2023 7:00 AM | Edgewise Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/03/2023 5:25 PM | Edgewise Therapeutics (Issuer) KOCH KEVIN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2023 5:25 PM | Donovan Joanne M. (Reporting) Edgewise Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2023 5:26 PM | Edgewise Therapeutics (Issuer) Russell Alan J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2023 5:26 PM | Carruthers R Michael (Reporting) Edgewise Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2023 5:26 PM | Edgewise Therapeutics (Issuer) MOORE JOHN R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2023 5:26 PM | Derakhshan Behrad (Reporting) Edgewise Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/28/2023 3:10 PM | Edgewise Therapeutics (Filer)
| Form DEFA14A | |